An Investigation of Mechanisms of Response and Resistance to Enfortumab Vedotin in Urothelial Cancer (PH-NIH_Enformtumab Vedotin)

Third party funded individual grant


Acronym: PH-NIH_Enformtumab Vedotin

Start date : 01.06.2024

End date : 31.05.2027

Project details

Involved:

Markus Eckstein Project Leader

Contributing FAU Organisations:

Institute of Pathology

Funding Source

National Institutes of Health (NIH)